Case Studies

October 17-21, 2009 • Lisbon, Portugal

ACTIVATED COLLAGEN ACCELERATES WOUND REPAIR AND MODULATES CYTOKINE PRODUCTION IN WHOLE BLOOD AND PBMC CULTURES.
Gregory B. Pott PhD, K. Scott Beard MS, Matthew Regulski DPM and Leland Shapiro MD


On July 9-11, 2009 • New Orleans, Louisiana

Clincal Uses of CellerateRX by Dr. Jane Fore.


April 26-28, 2009 • Dallas, Texas

Cellerate was presented in two abstracts:

Emerging Use of Topical Biologics in Limb Salvage: The Role of "Activated Collagen" in the Multimodality Treatment.

CellerateRx: An Evidence Based Skin Tear Study: Interim Evaluation.


March 19-21, 2009 • Los Angeles, California

Cellerate was presented in an abstract titled:

Activated Collagen an Evidence Based Study (Interim Data) in Human Leg Ulcers.


November/December 2008

APWCA Case #1: Using Combined Treatment Modalities for Successful Wound Healing.


September 10-13, 2008 • New Orleans, Louisiana

Cellerate was highlighted during Dr. Gary Rothenberg's presentation titled:

Emerging Use of Topical "Biologics" in Limb Salvage: Role of "Activated Collagen" in Multimodality Treatment.


April 24-26, 2008 • San Diego, Callifornia

Cellerate was presented in an abstract titled:

Wound Pain Reduction with Hydrolyzed Collagen.


August 2008

Published in the issue of Advances in Skin & Wound Care

Activated, Type I Collagen (CellerateRx) and Its Effectiveness in Healing Recalcitrant Diabetic Wounds: A Case Presentation.


CellerateRX Case Study: CS02A: Arterial Wound
CellerateRX Case Study: CS03B: 1st and 2nd Degree Burns of the Leg and Arm
CellerateRX Case Study: CS04P: Stage III Pressure Ulcer
CellerateRX Case Study: CS05P: Stage III Pressure Ulcer

 

 

   

Pharma Technology International, LLC • 2275 Swallow Hill Road • Building 1200 • Pittsburgh, PA 15220 • USA
412-722-0250 • Fax 412-279-7665
©2010 • All Rights Reserved